• HOME
• COMPANY
  • BOARD OF DIRECTORS
  • MANAGEMENT
  • PARTNERSHIPS
  • CAREERS
• VACCINES
  • MODITOPE
    • Modi-1
    • Modi-2
  • IMMUNOBODY
    • SCIB1 & iSCIB1+
    • SCIB2 & iSCIB2
    • COVIDITY
  • VACCINE PUBLICATIONS
• ANTIBODIES
  • GLYMAB
    • ANTI-GLYCAN MAB
  • AVIDIMAB
  • ANTIBODY PUBLICATIONS
• INVESTORS
  • COMPANY PROFILE
  • ADVISORS
  • CORPORATE GOVERNANCE
  • DIRECTORS
  • DOCUMENTS & PRESENTATIONS
  • SHARE INFO
  • FINANCIAL INFO
  • 2023 CAPITAL RAISE
  • 2020 CAPITAL RAISE
  • REGULATORY NEWS
  • REGULATORY NEWS ARCHIVE
• NEWS
  • LATEST NEWS
  • INTERVIEWS
  • MEDIA COVERAGE
  • WEBCASTS
  • YEAR - 2024
  • YEAR - 2023
  • YEAR - 2022
  • YEAR - 2021
  • YEAR - 2020
  • YEAR - 2019
  • YEAR - 2018
  • YEAR - 2017
  • YEAR - 2016
• CONTACT US